Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Galirayo who wrote (991)	6/8/2005 11:51:50 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

IMCL Opened on an up-gap today and is up more than 14%<g> It announced today that a "late-stage study" confirmed that Erbitux is effective in preventing the spread of head and neck cancer.( The FDA has already approved it for colon Ca.) Carl Icahn already owns 5M shares and is planning to buy more.He took advantage of the drop on IMCL stock after poor Martha sold hers.<g> IMCL still has to close above its Apr.6 H of 36.26 to get off the downtrend coming from the Feb.25 H of 45.94 bigcharts.marketwatch.com The Jul.30 calls of IMCL (QCIFF) are trading around $4.60 already up $3.40 , not a bad % gain.<g> Bernard